Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

The Role and Therapeutic Target of Base Excision Repair Genes in Multiple Myeloma (MM)

Rumi Ino, Takayuki Saitoh, MD PhDProf, Yuya Kitamura, Kazuki Homma, Noriyuki Takahashi, Gotoh Nanami, Master, Tetsuhiro Kasamatsu, PhD, Hiroaki Shimizu, MD PhD, Makiko Takizawa, PhDMD, Morio Matsumoto, MD, Morio Sawamura, MD PhD, Akihiko Yokohama, MD PhD, Norifumi Tsukamoto, MDPhDChief Division, Hiroshi Handa, MD PhDChief Division, Hirokazu Murakami, MDPhDProf

Blood (2017) 130 (Supplement 1): 4403.

https://doi.org/10.1182/blood.V130.Suppl_1.4403.4403

Published: 2017

Journal Articles

Retrospective Analysis of Prognostic Factors for Waldenström Macroglobulinemia: A Multicenter Cooperative Study in Japan

Blood (2015) 126 (23): 5028.

https://doi.org/10.1182/blood.V126.23.5028.5028

Published: 2015

Journal Articles

Soluble IL-2 Receptor α Is a More Sensitive Diagnostic Biomarker Than β2 Microglobulin and Predicts Survival in Follicular Lymphoma: Retrospective Analysis of 305 Cases

Blood (2014) 124 (21): 3034.

https://doi.org/10.1182/blood.V124.21.3034.3034

Published: 2014

Journal Articles

Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Shuji Ozaki, Hiroshi Handa, MD PhD, Takayuki Saitoh, MD, PhD, Hirokazu Murakami, MD, PhD, Mitsuhiro Itagaki, MD, Hideki Asaoku, MD, Kenshi Suzuki, MD PhD, Atsushi Isoda, MD PhD, Morio Sawamura, MD PhD, Jun Konishi, MD, Kazutaka Sunami, Naoki Takezako, MD PhD, Shotaro Hagiwara, MD PhD, Yoshiaki Kuroda, MD PhD, Takaaki Chou, Eiko Shibata, Kazuyuki Shimizu, MD, Eiichi Nagura, MD

Blood (2014) 124 (21): 5684.

https://doi.org/10.1182/blood.V124.21.5684.5684

Published: 2014

Journal Articles

Impact Of Sex On Clinical Outcomes Of Mature B Cell Lymphoma In The Rituximab Era: A Multicenter, Retrospective Study

Hiroyuki Nakamura, MD, Hirokazu Nagai, MD, PhD, Tomoyuki Watanabe, PhD, Takahiro Yano, MD, PhD, Naokuni Uike, MD, PhD, Seiichi Okamura, Shuichi Hanada, Fumio Kawano, MD, PhD, Kazutaka Sunami, MD, PhD, Nobumasa Inoue, Shin-ichiro Yoshida, Takeshi Shimomura, MD, Kiyoshi Kitano, MD, Morio Sawamura, M.D. Ph.D., Keizo Horibe, MD, PhD

Blood (2013) 122 (21): 5056.

https://doi.org/10.1182/blood.V122.21.5056.5056

Published: 2013

Journal Articles

Intensified Rituximab Induction Followed By Rituximab Maintenance For Low Grade B Cell Lymphoma: A Multicenter, Phase II Study

Kyouhei Yamada, M.D., Morio Sawamura, M.D. Ph.D., Takeshi Shimomura, MD, Makoto Takeuchi, M.D., Shuichi Hanada, Takuya Komeno, MD, PhD, Michihiro Hidaka, MD, PhD, Takahiro Yano, MD, PhD, Kiyoshi Kitano, MD, Isao Yoshida, MD, Nobumasa Inoue, Keizo Horibe, MD, PhD, Watanabe Tomoyuki, Kazutaka Sunami, MD, PhD, Hirokazu Nagai, MD, PhD

Blood (2013) 122 (21): 1797.

https://doi.org/10.1182/blood.V122.21.1797.1797

Published: 2013

Journal Articles

The Polymorphisms of Base Excision Repair Genes Influence the Prognosis of Multiple Myeloma

Chiaki Ushie, Takayuki Saitoh, M.D. Ph.D., Atsushi Iwasaki, Norihiko Moriyama, Hikaru Hattori, Morio Matsumoto, MD, Morio Sawamura, M.D. Ph.D., Jun Isoda, M.D. Ph.D., Hiroshi Handa, M.D. Ph.D., Akihiko Yokohama, MD, PhD, Norifumi Tsukamoto, MD, PhD, Hatsue Ogawara, Ph.D., Hirokazu Murakami, M.D., Ph.D.

Blood (2012) 120 (21): 3981.

https://doi.org/10.1182/blood.V120.21.3981.3981

Published: 2012

Journal Articles

Polymorphisms of IL-10, IL-17A, IL-17F and IL-18 Affect the Clinical Features of Multiple Myeloma in Japanese Patients

Atsushi Iwasaki, Takayuki Saitoh, M.D. Ph.D., Chiaki Ushie, Norihiko Moriyama, Tomonori Takani, Hikaru Hattori, Hiroshi Handa, M.D. Ph.D., Morio Matsumoto, MD, Jun Isoda, M.D. Ph.D., Morio Sawamura, M.D. Ph.D., Hatsue Ogawara, Ph.D., Hirokazu Murakami, M.D. Ph.D.

Blood (2012) 120 (21): 4972.

https://doi.org/10.1182/blood.V120.21.4972.4972

Published: 2012

Journal Articles

Relation of IL-18 Polymorphism to the Susceptibility and Clinical Feature of Multiple Myeloma in Japanese Patients

Takayuki Saitoh, M.D. Ph.D., Norihiko Moriyama, Tomonori Takani, Chiaki Ushie, Takumi Hoshino, M.D., Takeki Mitsui, M.D. Ph.D., Hiromi Koiso, M.D. Ph.D., Akihiko Yokohama, M.D. Ph.D., Hiroshi Handa, M.D. Ph.D., Norifumi Tsukamoto, M.D. Ph.D., Hatsue Ogawara, Ph.D., Morio Sawamura, M.D. Ph.D., Yoshihisa Nojima, M.D. Ph.D., Hirokazu Murakami, M.D. Ph.D.

Blood (2011) 118 (21): 5062.

https://doi.org/10.1182/blood.V118.21.5062.5062

Published: 2011

Journal Articles

Common Fragile Site Gene FRA16D WWOX (WW domain containing oxidoreductase) Is Frequently Altered in Plasma Cells of Multiple Myeloma and MGUS, Possibly Related to Disease Development

Yoshiko Sasaki, Hiroshi Handa, M.D. Ph.D., Noriyuki Takahashi, Hikaru Hattori, Takayuki Saitoh, M.D. Ph.D, Yohei Osaki, MD, Morio Matsumoto, MD, Atsushi Isoda, MD, PhD, Morio Sawamura, M.D. Ph.D., Akio Saito, MD, Akihiko Yokohama, M.D. Ph.D., Hiromi Koiso, M.D. Ph.D., Takeki Mitsui, M.D. Ph.D., Norifumi Tsukamoto, M.D. Ph.D., Yoshihisa Nojima, M.D. Ph.D., Hirokazu Murakami, M.D. Ph.D.

Blood (2011) 118 (21): 4646.

https://doi.org/10.1182/blood.V118.21.4646.4646

Published: 2011

Journal Articles

Significantly Reduced Circulating Plasmacytoid Dendritic Cells In Patients with Primary and Helicobacter Pylori -Associated Immune Thrombocytopenia

Akio Saito, MD, Akihiko Yokohama, MD, PhD, Yohei Osaki, MD, Yoshiyuki Ogawa, MD, Takeki Mitsui, MD, PhD, Hideki Uchiumi, MD, Takayuki Saitoh, MD, PhD, Hiroshi Handa, MD, PhD, Morio Sawamura, MD, PhD, Masamitsu Karasawa, MD, PhD, Hirokazu Murakami, MD, PhD, Yoshihisa Nojima, MD, PhD, Norifumi Tsukamoto, MD, PhD

Blood (2010) 116 (21): 2531.

https://doi.org/10.1182/blood.V116.21.2531.2531

Published: 2010

Journal Articles

Prognostic Importance of Soluble Form IL-2 Receptor á (sIL-2Rá) and Its Relationship with Surface Expression of IL-2Rá of Lymphoma Cell in Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy: a Retrospective Analysis of 409 Cases.

Akihiko Yokohama, Yoko Hashimoto, Akio Saito, Hirotaka Nakahashi, Kohtaro Toyama, Hiromi Koiso, Takayuki Saito, MD, Hiroshi Handa, Hideki Uchiumi, Takahiro Jimbo, Kayoko Murayama, Morio Sawamura, Morio Matsumoto, Masamitsu Karasawa, Hirokazu Murakami, MD, Yoshihisa Nojima, Junko Hirato, Masaru Kojima, Norifumi Tsukamoto

Blood (2009) 114 (22): 1935.

https://doi.org/10.1182/blood.V114.22.1935.1935

Published: 2009

Journal Articles

Innate Immunity in Idiopathic Thrombocytopenic Purpura (ITP)

Akio Saito, Akihiko Yokohama, Hirotaka Nakahashi, Kohtaro Toyama, Takeki Mitsui, Yoko Hashimoto, Hiromi Koiso, Takayuki Saitoh, Hideki Uchiumi, Hiroshi Handa, Morio Sawamura, Masamitsu Karasawa, Hirokazu Murakami, Yoshihisa Nojima, Norifumi Tsukamoto

Blood (2008) 112 (11): 4907.

https://doi.org/10.1182/blood.V112.11.4907.4907

Published: 2008

Journal Articles

IL-10-592 Polymorphism Predicts the Clinical Outcome of Japanese Patients with Multiple Myeloma and MGUS.

Tetsuhiro Kasamatsu, Takayuki Saitoh, Hiroshi Handa, Takafumi Matsushima, Norifumi Tsukamoto, Masamitsu Karasawa, Hatsue Ogawara, Morio Sawamura, Yohihisa Nojima, Hirokazu Murakami

Blood (2007) 110 (11): 4759.

https://doi.org/10.1182/blood.V110.11.4759.4759

Published: 2007

Journal Articles

Addition of Rituximab Improves Progression-Free and Overall Survival in Patients with B-Cell Lymphoma Receiving Doxorubicin-Containing Chemotherapy

Tatsunori Sakai, Hirokazu Nagai, Tomoyuki Watanabe, Naokuni Uike, Seiichi Okamura, Takahiro Yano, Fumio Kawano, Shuichi Hanada, Kazutaka Sunami, Hirokazu Ikeda, Morio Sawamura, Tetsuo Nishiura, Tomomitsu Hotta, Keizo Horibe

Blood (2007) 110 (11): 1292.

https://doi.org/10.1182/blood.V110.11.1292.1292

Published: 2007

Journal Articles

Thalidomide-Induced Leukopenia in Japanese Patients with Refractory Multiple Myeloma.

Blood (2006) 108 (11): 5089.

https://doi.org/10.1182/blood.V108.11.5089.5089

Published: 2006

Journal Articles

Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia

Takafumi Matsushima, Hiroshi Handa, Akihiko Yokohama, Jun Nagasaki, Hiromi Koiso, Yoshitora Kin, Yoko Tanaka, Tohru Sakura, Norifumi Tsukamoto, Masamitsu Karasawa, Katsuhiko Itoh, Hisami Hirabayashi, Morio Sawamura, Shogo Shinonome, Shun-ichi Shimano, Shuichi Miyawaki, Yoshihisa Nojima, Hirokazu Murakami

Blood (2003) 101 (9): 3386–3390.

https://doi.org/10.1182/blood-2002-03-0947

Published: 2003

NARROW

The Role and Therapeutic Target of Base Excision Repair Genes in Multiple Myeloma (MM)

Retrospective Analysis of Prognostic Factors for Waldenström Macroglobulinemia: A Multicenter Cooperative Study in Japan

Soluble IL-2 Receptor α Is a More Sensitive Diagnostic Biomarker Than β2 Microglobulin and Predicts Survival in Follicular Lymphoma: Retrospective Analysis of 305 Cases

Survival of Multiple Myeloma Patients in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma

Impact Of Sex On Clinical Outcomes Of Mature B Cell Lymphoma In The Rituximab Era: A Multicenter, Retrospective Study

Intensified Rituximab Induction Followed By Rituximab Maintenance For Low Grade B Cell Lymphoma: A Multicenter, Phase II Study

The Polymorphisms of Base Excision Repair Genes Influence the Prognosis of Multiple Myeloma

Polymorphisms of IL-10, IL-17A, IL-17F and IL-18 Affect the Clinical Features of Multiple Myeloma in Japanese Patients

Relation of IL-18 Polymorphism to the Susceptibility and Clinical Feature of Multiple Myeloma in Japanese Patients

Common Fragile Site Gene FRA16D WWOX (WW domain containing oxidoreductase) Is Frequently Altered in Plasma Cells of Multiple Myeloma and MGUS, Possibly Related to Disease Development

Significantly Reduced Circulating Plasmacytoid Dendritic Cells In Patients with Primary and Helicobacter Pylori -Associated Immune Thrombocytopenia

Prognostic Importance of Soluble Form IL-2 Receptor á (sIL-2Rá) and Its Relationship with Surface Expression of IL-2Rá of Lymphoma Cell in Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy: a Retrospective Analysis of 409 Cases.

Innate Immunity in Idiopathic Thrombocytopenic Purpura (ITP)

IL-10-592 Polymorphism Predicts the Clinical Outcome of Japanese Patients with Multiple Myeloma and MGUS.

Addition of Rituximab Improves Progression-Free and Overall Survival in Patients with B-Cell Lymphoma Receiving Doxorubicin-Containing Chemotherapy

Thalidomide-Induced Leukopenia in Japanese Patients with Refractory Multiple Myeloma.

Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only